chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediate ( within 2 minutes) onset of tongue swelling, throat tightening, confusion. In car at head of line, so drove off to side, parked car, did not get out to seek medical attention. Symptoms began to decline after about 5 minutes and lasted in total approximately 45 minutes. Patient went home took Benadryl immediately and repeated dose of Benadryl 6 hours later. No recurrence, no medical attention, but called this physician reporter who urged immediate reporting to VAERS and advised against additional vaccination.
BLOOD CLOT IN ARM; HARD TIME BREATHING/COULDN'T BREATH; HIGH FEVER; This spontaneous report received from a a 63-year-old female patient of unspecified of race and ethnic origin and her daughter via a traditional media  and via a company representative. The patient's height, and weight were not reported. The patient's concurrent condition included diabetes. The patient never tested positive for coronavirus disease (COVID). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration was not reported, batch number: unknown, and expiry date: unknown) dose was not reported, 1 total, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, in APR-2021, shortly after the vaccination, the patient experienced a high fever. A day later, the patient had a hard time breathing/could not breath and was rushed to the hospital (date unspecified). The patient also developed a blood clot in her arm. The doctors told the patient's kids that the patient might not recover. In a hospital bed, the patient spent 21 days on a ventilator. The patient was recovering in the hospital in the last month of MAY-2021 and was expected to leave the rehabilitation facility by the end of JUN-2021. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from high fever, hard time breathing/couldn't breath, and blood clot in arm. This report was serious (Hospitalization Caused / Prolonged, and Life Threatening).; Sender's Comments: V0: 20210619186-COVID-19 VACCINE AD26.COV2.S-Blood clot in arm, Hard time breathing/couldn't breath, High fever. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Pt described inflamation of the arm where it presents hot and swollen from collarbone to elbow. Pt also stated she was not sure if it was the vaccine or cellulitis.
This spontaneous case was reported by an other health care professional and describes the occurrence of DEPRESSED MOOD (disappointed To have) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEPRESSED MOOD (disappointed To have). At the time of the report, DEPRESSED MOOD (disappointed To have) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant product was reported. No treatment medication was reported.
My temperature went up to 109.9 to 102 F; I felt drained, and tired; Coughing; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A female patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on 24Apr2021 at single dose for COVID-19 immunization. Medical history included ongoing smoker. Concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization and experienced coughing. In Apr2021, the patient temperature went up to 109.9 Fahrenheit to 102 Fahrenheit and the patient felt drained and tired. The patient asked whether she could catch COVID-19 in between the doses since she had been coughing even though she was a smoker. The patient took Tylenol throughout the last day (as of 26Apr2021) and the body temperature dropped to 98.6 Fahrenheit, but the patient's normal temperature usually runs in the 96 Fahrenheit. The patient asked whether these events were side effects of the vaccine. The outcome of the event temperature went up to 109.9 to 102 Fahrenheit was recovering and outcome of other events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
2-3 days after receiving dose 1 of monkeypox (mpox) vaccine on right forearm, began to have small, hard bumps that were present in medial aspect of right upper arm. No erythema. Skin colored nodules that were ~4-5mm wide. The nodules would come and go. No lymphadenopathy. Total # of nodules was 7-8.
4/13/06 PM fever 101.3 developed hard lump on left deltoid. 4/14/2006 AM fever 102 lump red hot to touch headache and vomiting X 2. 4/16/2006 PM fever 102 c/o pain in left arm remains red lump hard. 4/17/2006 no fever moving arm freely lump hard no redness.
Attacked my immune system in my back, hips and legs.  It was so painful I could hardly walk.  Tried several different medications and ended up taking Sulindac.  80% better with the Sulindac and with therapy  over the last couple of months.
Woke up with severe chills and body aches, especially in the lower back region.  Progressed into nausea within 30 minutes.  Fever fluctuating between 0.5-2 degrees above normal body temp.  Nausea and chills subsided after about 2 hours, body aches dulled.  Headache and severe fatigue persisted the entire rest of the day.
Pt initially tested positive back on 12/16/2020.  She was subsequently vaccinated with the Pfizer vaccine on 2/1/2021 and 2/22/2021.  She tested negative on 6/1/2021 and 6/20/2021.  As part of SNF admission requirement, she was tested upon discharge from hospital on 7/5/2021 and it resulted positive.  Pt was here for non covid reasons and was admitted on 6/20/2021, negative on admit.  CT value was over 30 and therefore the viral replication is insignificant for sequencing .  She had subsequent negative COVID tests on 7/6/2021 and 7/7/2021.  Remained asymptomatic for covid.
Shot was given on Monday 12/28/2020, the next day Tuesday 12/29/2020  severe arm pain at injection site, ending on  Wednesday 12/30/2020 also on Wednesday 12/30/2020 severe migraine, that turned into a dull headache lasting for 1 week after onset of migraine ending on 1/6/2021, dizziness on Saturday 1/2/2020 with fatigue . All symptoms resolved on 1/6/2021
Pain in right heel; Sore Left Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in right heel) and VACCINATION SITE PAIN (Sore Left Arm) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     Concurrent medical conditions included Bursitis.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in right heel) and VACCINATION SITE PAIN (Sore Left Arm). On 03-Feb-2021, VACCINATION SITE PAIN (Sore Left Arm) had resolved. On 18-Feb-2021, PAIN IN EXTREMITY (Pain in right heel) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessment.  About three weeks after the first vaccine, on 18-FEB-2021, patient had a cortisone shot in the heel of her right foot.  No concomitant medications were reported. Treatment information was not provided.
Swelling at injection site and then pain, swelling the next day in my lymph nodes under my arm. Hard knots in my arm pit.
Patient fainted during administration of vaccines x 2 seconds. At 2:42pm BP 97/59. At 2:50pm BP 100/65, continue to monitor patient x30 minutes, vital signs stable. BP 101/63 P 71 R:18 T:98.0. Pt. verbalizes she feels okay. ER precautions discussed with mom.
J96.00 ACUTE RESPIRATORY FAILURE 10/4/2021 BPH W LOWER URINARY TRACT SYMPTOMS
Symptoms of blurred vision at longer distances. I wear no prescription glasses. I have never had eye issues all through my life. I have been recorded to have 20/20 vision all through my life. Starting on the date documented. I began having slightly blurred vision at far distances. This has not been a usual occurrence for me all my life. This symptom has started approximately 1 week after a vaccine injection. I have yet to receive medical attention. It is not life threatening at the moment. However it is quite alarming and brought on suddenly.
Feeling tightness on the face for around 45 min. Blurred vision, very dizzy and unable to have good balance for 6 days.
Shoulder and deltoid swollen twice to the size, red hot painful. Sometimes itchy.  I treated with ice, Tylenol, Motrin.
Hospitalization  - supportive care only. Not requiring steroids, no remdesivir or steroids
BLOOD CLOT IN LEG; LEFT LEG AMPUTATION; PULLED MUSCLE; CORONAVIRUS 19; CONFIRMED CLINICAL VACCINATION FAILURE; FELT QUEASY; This spontaneous report received from a patient concerned a 45 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: high blood pressure, non alcohol user, and non-smoker. The patient experienced dystonic and muscle spasms on the neck when treated with prochlorperazine.  The patient received covid-19 vaccine ad26.cov2.s (Janssen series 1) (suspension for injection, route of admin not reported, batch number: 203A21A and expiry: 23-JUN-2021) dose was not reported, 1 total, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-APR-2021, the patient experienced felt queasy. On an unspecified date of JUN-2021, (at the beginning of month) the patient experienced coronavirus 19 and had confirmed clinical vaccination failure. Laboratory data included: COVID-19 PCR (coronavirus-19 polymerase chain reaction) test (NR: not provided) positive. On an unspecified date, the patient went to urgent care for foot was limp and there was no blood flow getting to patient leg. At first it diagnosed with pulled muscle. A week after the patient again went to emergency room and they stated pulling blood clots out. After that on next day the patient was hospitalized with diagnosis of blood clots in leg. The patient stayed in the hospital for about a month. On an unspecified date of AUG-2021, during hospitalization, the patient had left leg amputation. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from coronavirus 19 on 30-JUN-2021, and felt queasy on 11-APR-2021, and the outcome of left leg amputation, pulled muscle, blood clot in leg and confirmed clinical vaccination failure was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition). This report was associated with regulatory authority 90000207277.; Sender's Comments: V0: 20211235762-COVID-19 VACCINE AD26.COV2.S-Blood clot in leg, Left leg amputation. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211235762-COVID-19 VACCINE AD26.COV2.S-Confirmed clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Rash, itchy, sore, red, at spot on arm of injection.  It hurt immediately after shot and two days after, then went away. And came back & days later.
Localized Rash medial to injection site on L. Deltoid. Bruising at injection site on L. Deltoid. General Left arm soreness. Symptoms occurred 24-48 hours post-vaccination.
Headache the following morning. Pain at vaccination site for 3 days.Tender, enlarged axillary lymph node on pectoralis minor on right side 5 days after vaccination.
a nut at the arm"; vaccination site swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (a nut at the arm") and VACCINATION SITE SWELLING (vaccination site swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE REACTION (a nut at the arm") and VACCINATION SITE SWELLING (vaccination site swelling). At the time of the report, VACCINATION SITE REACTION (a nut at the arm") and VACCINATION SITE SWELLING (vaccination site swelling) outcome was unknown.            No concomitant medications reported by investigator.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
pt recvd vax approx 2 mins p/vax-face blue, extended neck & clenched fists, momentary apnea; then resumed w/shallow resp, skin color pale;
arm was hurting; large rash; did not receive second dose in dosing window; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was hurting), RASH (large rash) and PRODUCT DOSE OMISSION ISSUE (did not receive second dose in dosing window) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was hurting), RASH (large rash) and PRODUCT DOSE OMISSION ISSUE (did not receive second dose in dosing window). At the time of the report, PAIN IN EXTREMITY (arm was hurting) and RASH (large rash) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (did not receive second dose in dosing window) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. No treatment information provided.
Erythema Multiforme formed 10 days after first vaccine.  5/921: Formed a rash on hands and arms that resembled poison ivy, itched terribly. Went to urgent care and was given a steroid shot and an antihistamine.  No change to current reaction, gotten worse as day progressed.  5/10/21: Rash had spread to feet, knees and elbows. Itched 10 times worse. Went back to urgent care, different doctor. Was diagnosed with hand foot mouth disease. Was given a nausea medication, a topical to dry up rash, and a stomach ulcer medication. No relief, no change.  5/11/21: rash now hurts and looked like cigarette burns. Can not close hands and walking is painful. Went to dermatologist. Was diagnosed with erythema multiforme and was given oral steroid for 16 days started at 40 mg and tapered down to 10 mg. Saw and felt immediate relief.  5/25/21: had follow up appointment with dermatologist. Was recommended not to get second vaccine as reaction could be worse and more threatening.
Pain at the injection site/tenderness to the touch at injection; headache; nausea; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 07Apr2021 at 04:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient did not take other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 00:00, the patient experienced pain at the injection site, tenderness to the touch at injection site, headache, nausea, fatigue. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain at the injection site, tenderness to the touch at injection site, headache, nausea, fatigue was resolving.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Breakthrough case admission after two vaccines Moderan 9/29/21 Lot# 006cz1A;  Moderna 10/27/21 Lot# 939904
Pain was torturous; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: Pain was torturous). The outcome of the pain was recovering/resolving.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 08-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he/she received Shingles vaccine and experienced pain that was torturous for 11 weeks and still  is there, but now much better. Follow-up would not possible as no contact details were available.
Severe headache, chills, body aches, eyes blood red and fever.  Called my Dr. then went to the hospital/emergency room.
Pt feels achy all over, SOB, muscles hurts, just feel really bad.  And states its not worse than how she normaly feels with her carotid syncope.  Pt and mom believes it is from the Gardasil shot.
Arm red, swollen and warm at injection site. Suggested she take BENADRYL 50 mg x one, ice and continue ibuprofen.
05Dec90 pt vax w/ MMR; 19Dec90 pt devel fever + maculopapular rash over entire body.
Received her first injection with Vaccine Clinic (Moderna) on 12/29/2020. She went to her PCP office where she then received a separate health maintenance vaccine on 01/21/2021.  When she presented for her second Moderna dose at Vaccine Clinic on 01/26/2021 they told he it was too soon to get the vaccine and sent her home.  When she called to reschedule, they told her that to get the second dose would fall outside the needed 28 day window and scheduled her to "re-start" her series.  She then presented to the General Public Vaccine Clinic on 02/04/2021 where she received the first dose of Pfizer vaccine. She did put on her form that it was her first vaccine, but when trying to administer the documentation in the electronic health record there was the warning that this would be a different medication which prompted the investigation.  Patient did receive both Moderna and Pfizer doses.
Pt was given first Rota at 7 months of age. Didn't check that patient hadn't ever received Rota. Wrong age (patient not correct age for vaccine given).
4 days p/vax rt thumb, then lt thumb began joint aches then moves to knuckles on lt hand, radiates through lt hand, rt hand thumb still aches;
lathargy began about 5 hrs after shot, muscle/joint soreness at 15-20 after shot, followed by low-grade fever & chills, severe headache. 48 after shot, lymph node swelling/soreness on left side of body.  Itchy/sore spot at injection site, nasal congestion.  * Also experiencing a symptom that I have not seen a lot about...swollen gums and canker sores on left side of mouth.
This is a spontaneous report from a contactable physician through a Pfizer sales representative. A 4-months-old female patient received PREVENAR 13, INFANRIX and ROTARIX, via an unspecified route of administration on unknown date. The patient medical history and the concomitant medications were not reported. The patient received the first dose of PREVENAR 13 on 30Apr2012. After the second vaccination on 29May2012 the patient experienced petechiae about 12 hours after the injection. The child had been hospitalized for observation and diagnosis but was discharged after 4 days without any findings in lab data. Several time later (unknown date) it was reported that the event petechiae had been recovered.
This spontaneous report was received from a registered nurse refers to unknown patients of unknown ages and gender. On an unknown date the patients were vaccinated with GARDASIL (lot #, expiration date and route not reported). The patients had been coming to the office later than recommended schedule for GARDASIL. No adverse effect reported. Additional information has been requested.
Pt received a 1st & 2nd dose of Engerix B & Hepatitis B vax, reporter thinks events of fever & lt side of body swelled occurred less than 24 hrs /p vax given, resolved
Patient was apparently pregnant at time of vaccine administration. Patient received 4 vaccines; patient was approximately 8 weeks pregnant.
Tightening of airways, shortness of breath, cough, swollen eyes, fever.